Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients

Archives of Dermatology

Volumn 146, Issue 1, 2010, Pages 89-91

  Guyot, Alexis ^a,b   Ortonne, Nicolas ^a   Valeyrie Allanore, Laurence ^a,b   Bagot, Martine ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER REGRESSION; CASE REPORT; CONGESTIVE HEART FAILURE; CYTOPENIA; DISSEMINATED CANCER; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; INFECTION; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; SKIN LYMPHOMA;

AGED, 80 AND OVER; ANTHRACYCLINES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VINCRISTINE;

EID: 74549135795     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.345     Document Type: Article

References (4)

1. Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg-type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol. 2007;143(9):1144-1150.
2. Senff NJ, Noordijk EM, Kim YH, et al; European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600-1609.
3. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97(11):2869-2879.
4. Balducci L, Cohen HJ, Engstrom P, et al; National Comprehensive Cancer Network. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3(4):572-590.